Clinical Trial Update: Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating sirolimus plus pemetrexed for non-small cell lung cancer was terminated after Phase 1/Phase 2, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)
• Sirolimus (Sirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2013-10-23